Skip to search formSkip to main contentSkip to account menu

S-2444

Known as: chromogenic substrate S-2444 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
THROMBOLYSIS Synergism of thrombolytic agents in vivo
The existence of significant synergism between tissue-type plasminogen activator (t-PA) and single-chain urokinase-type… 
Highly Cited
1986
Highly Cited
1986
Plasminogen activator in bronchoalveolar fluid.
Plasminogen activator was purified from the soluble fraction of bronchoalveolar lavage fluid, and biological and immunological… 
1986
1986
Functional assay of plasminogen activator by hydrolysis of 14C-globin.
A functional method for estimation of plasminogen activator (PA) activity is described. The end-point method follows the PA… 
1983
1983
[The changes of alpha 2-plasmin inhibitor, and notably urokinase activities in blood measured by synthetic chromogenic substrates S-2444 after urokinase administration].
Thrombolytic therapy with Urokinase (UK) has often been successful but it is very difficult to determine the effective dosage of… 
1982
1982
[Kinetics of urokinase hydrolysis of low molecular weight substrates].
The kinetics of urokinase hydrolysis of the low molecular weight substrates--S-2444 (Glu-Gly-Arg-pNA.HCl), N-benzoyl-L-arginine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)